期刊文献+

TAK1 siRNA对类风湿性关节炎患者滑膜细胞中mmp9和timp1表达的影响 被引量:3

Effects of TAK1 on Gene Expressions of Matrix Metalloproteinase 9 and timp1 in Rheumatoid Arthritis Patients′ Fibroblast Synoviocytes
在线阅读 下载PDF
导出
摘要 目的实验观察转化生长因子β激活激酶(TAK1)对滑膜细胞中基质金属蛋白酶9(mmp9)和基质金属蛋白酶抑制剂1(timp1)表达的作用。方法收集行膝关节置换术的11例类风湿关节炎(RA)患者滑膜组织标本,酶消化法对滑膜成纤维细胞(FLS)体外培养。采用转染的方法将TAK1特异的小干扰RNA(siRNA)分子导入RA患者滑膜细胞,采用实时荧光定量PCR方法分析细胞内mmp9和timp1基因的相对表达。结果用特异性siRNA沉默TAK1前后,mmp9实验组降低率为74.76%。timp1实验组沉默率31.51%。结论抑制TAK1在RA滑膜细胞中的表达,虽然同时下调timp1 mRNA和mmp9 mRNA表达,但是两者之间的平衡关系被明显打破。 Objective To investigate effects of TAK1 on gene expressions of mmp9 and timpl in human fibroblast synoviocytes. Methods The samples of synovial tissues were obtained from 11 Rheumatoid Arthritis patients during knee joint replacement surgery. The synovial fi- broblasts were isolated by enzyme digestion. The chemically synthesized TAK1 siRNA was transferred into in vitro cultured synovioeytes by Lipofeetamine. RT-PCR was used to detect the expressions of nunp9 and timpl mRNA. Results The expressions of mmp9 and timpl mRNA in the cells transfeeted with TAKI siRNA were decreased by 74.76% and 31.51%,respectively. Conclusion The expressions of romp9 and timpl were decreased simultaneously via down-regulating the TAK1 expression, hut the balance of relations between the two were broken.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2012年第6期540-543,共4页 Journal of China Medical University
基金 辽宁省自然科学基金项目(2008225019)
作者简介 作者简介:兰忠煜(1984-),男,硕士 通讯作者:白希壮,E-mail:zpmmh@sina.com
  • 相关文献

参考文献8

  • 1Stephen AP,Allan G,John FB. Rheumatoid arthritisl In:Stephen AP.Manual of rheumatology and outpatient orthopedic disorders [ M ].天津:科技翻译出版公司,2003:192-291.
  • 2任洁,李娟,冯知涛,吕卓.类风湿关节炎患者滑液NK-22细胞对成纤维样滑膜细胞增殖的影响及其机制研究[J].南方医科大学学报,2011,31(4):661-664. 被引量:9
  • 3Cohen S,Fleischmann R. Kinase inhibitors:a new approach to rheuma- toid arthritis treatment[J ]. Curr Opin Rheumatol, 2010,22 (3) : 330- 335.
  • 4Liu G, Rondinone CM. JNK:bridging the insulin signaling and in- flammatory pathway IJ]. Curr Opin Investig Drugs,2005,6 (10) : 979-987.
  • 5Dai SM, Shan ZZ. Implication of interleukin 18 in production of ma- trix metalloproteinases in articular chondrocytes in arthritis:direct effect on chondrocytes may not be pivotal [J]. Ann Rheum Dis, 2005,64(5 ) : 735-742.
  • 6Geurts J,van den Brand BT. Toll-like receptor 4 signalling is specifi- cally TGF-beta-activated kinasc 1 independent in synovial fibroblasts [ J ]. Rheumatology (Oxford), 2011,50(7) : 1216-1225.
  • 7Hammaker DR,Boyle DL,Inoue T,et al. Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis syn- oviocytes[ J ]. Arthritis Res Ther, 2007,9(3 ) : R57.
  • 8Hegemann N,Wondium A,Ulricll K,et al. Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in ca- nine rheumatoid arthritis [ J 1. Vet Immunol Immunopathol, 2003,91 (3-4) : 199-204.

二级参考文献13

  • 1Flodstrom M, Shi FD, Sarvetnick N, et al. The natural killer cell-friend or foe in autoimmune disease [J]? Scand J Immunol, 2002, 55(5): 432-41.
  • 2Dalbeth N, Gundle R, Davies R J, et al. CD56 bright NK Cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation [J]. J Immunol, 2004, 173(10): 6418-26.
  • 3Pridgeon C, Lennon GP, Pazmany L, et al. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56 bright, CD94 bright, CD158 negative phenotype[J]. Rheumatology, 2003, 42: 870-8.
  • 4de Matos CT, Berg L, Michaelsson J, et al. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion [J]. Immunology, 2007, 122(2): 291-301.
  • 5Cella M, Fuchs A, Vermi W,et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity [J]. Nature, 2009, 457(5): 722-5.
  • 6James P, Santo D. Functionally distinct NK-cell subsets: Developmental origins and biological implications [J]. Eur J Immunol, 2008, 38(11): 2948-51.
  • 7Cooper MA, Fehniger TA, Fuchs A, et al. NK cell and DC interactionsIJ]. Trends Immunol, 2004, 25(1): 47-52.
  • 8Zingoni A, Sornasse T, Cocks BG, et al. NK cell regulation of T cell mediated responses[J]. Mol Immunol, 2005, 42(4): 451-4.
  • 9Grunebaum E, Malatzky-Goshen E, Shoenfeld Y. Natural killer cells and autoimmunity[J]. Immunol Res, 1989, 8(4): 292-304.
  • 10Ikeuchi H, Kuroiwa T, Hiramatsu N, et al. Expression of interleukin-22 in rheumatoid arthritis[J]. Arthritis Rheum, 2005, 52 (4): 1037-46.

共引文献8

同被引文献66

  • 1吴东海.类风湿关节炎的早期诊断[J].中国实验诊断学,2005,9(1):17-18. 被引量:7
  • 2陈巧林,李茹,张翠华,栗占国.小分子干扰RNA对人类白细胞抗原DRβ1^* 0401基因表达的抑制作用[J].中华医学杂志,2005,85(22):1568-1570. 被引量:4
  • 3郭大文,罗军,王晔,马晓锋,胡晓芳,孟冬娅.实时定量PCR检测类风湿关节炎滑液单个核细胞MIP-1α mRNA的表达[J].中国实验诊断学,2006,10(11):1303-1306. 被引量:2
  • 4Sioud M,Mel bye O,Forre O. Analysis of the NF-κB p65 subunit,Fas antigen,Gas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA[J].Clinical and Experimental Rheumatology,1998,(02):125-134.
  • 5Pinkenburg O,Platz J,Beisswenger C. Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virus[J].Journal of Virological Methods,2004,(01):119-122.doi:10.1016/j.jviromet.2004.04.007.
  • 6Philippe L,Alsaleh G,Suffert G. TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes[J].Journal of Immunology,2012,(01):454-461.
  • 7Bottini N,Firestein GS. Duality of fibroblast-like synoviocytes in RA:passive responders and imprinted aggressors[J].Nat Rev Rheumatol,2013,(01):24-33.
  • 8Hannon GJ. RNA interference[J].Nature,2002,(6894):244-251.
  • 9Fire A,Xu S,Montogonmry MK. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,(6669):806-8l1.
  • 10Buchan G,Barrett R,Tuner M. Interleukin-1 and tumor necrosis factor mRNA epression in rheumatoid arthritis:prolonged production of IL-1 alpha[J].Journal of Immunology,2000,(03):1576-1581.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部